These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15272477)

  • 1. A single-LTR HIV-1 vector optimized for functional genomics applications.
    Ma H; Kafri T
    Mol Ther; 2004 Jul; 10(1):139-49. PubMed ID: 15272477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration.
    Logan AC; Haas DL; Kafri T; Kohn DB
    J Virol; 2004 Aug; 78(16):8421-36. PubMed ID: 15280451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
    Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
    Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization.
    Hu P; Bi Y; Ma H; Suwanmanee T; Zeithaml B; Fry NJ; Kohn DB; Kafri T
    Gene Ther; 2018 Oct; 25(7):454-472. PubMed ID: 30190607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high excision potential of TALENs for integrated DNA of HIV-based lentiviral vector.
    Ebina H; Kanemura Y; Misawa N; Sakuma T; Kobayashi T; Yamamoto T; Koyanagi Y
    PLoS One; 2015; 10(3):e0120047. PubMed ID: 25781496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells.
    Moldt B; Miskey C; Staunstrup NH; Gogol-Döring A; Bak RO; Sharma N; Mátés L; Izsvák Z; Chen W; Ivics Z; Mikkelsen JG
    Mol Ther; 2011 Aug; 19(8):1499-510. PubMed ID: 21468003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
    Junker U; Böhnlein E; Veres G
    Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site.
    Choulika A; Guyot V; Nicolas JF
    J Virol; 1996 Mar; 70(3):1792-8. PubMed ID: 8627702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the central polypurine tract on the kinetics of human immunodeficiency virus type 1 vector transduction.
    Van Maele B; De Rijck J; De Clercq E; Debyser Z
    J Virol; 2003 Apr; 77(8):4685-94. PubMed ID: 12663775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 replication by an HIV-1 dependent ribozyme expression vector with the Cre/loxP (ON/OFF) system.
    Habu Y; Miyano-Kurosaki N; Nagawa T; Matsumoto N; Takeuchi H; Takaku H
    Antivir Chem Chemother; 2002 Sep; 13(5):273-81. PubMed ID: 12630675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of integration and replication on transcription of the HIV-1 long terminal repeat.
    Jeang KT; Berkhout B; Dropulic B
    J Biol Chem; 1993 Nov; 268(33):24940-9. PubMed ID: 8227056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
    Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
    Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of HIV-1 dependent gene expression vector with the Cre/loxP (ON) system.
    Nagawa T; Habu Y; Matsumoto N; Takeuchi H; Kurosaki N; Takaku H
    Nucleic Acids Res Suppl; 2002; (2):295-6. PubMed ID: 12903221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rev-dependent lentiviral expression vector.
    Wu Y; Beddall MH; Marsh JW
    Retrovirology; 2007 Feb; 4():12. PubMed ID: 17286866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the internal promoter on insertional gene activation by lentiviral vectors with an intact HIV long terminal repeat.
    Knight S; Bokhoven M; Collins M; Takeuchi Y
    J Virol; 2010 May; 84(9):4856-9. PubMed ID: 20181689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HIV-1 replication by the Cre-loxP hammerhead ribozyme.
    Habu Y; Miyano-Kurosaki N; Takeuchi H; Matsumoto N; Tamura Y; Takaku H
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):723-6. PubMed ID: 11563101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shuttle system allowing simplified cloning of expression cassettes into advanced generation lentiviral vectors.
    Gruh I; Schwanke K; Wunderlich S; Blömer U; Scherr M; Ganser A; Haverich A; Martin U
    Biotechniques; 2005 Apr; 38(4):530, 532, 534. PubMed ID: 15884668
    [No Abstract]   [Full Text] [Related]  

  • 19. Self-inactivating lentiviral vectors with U3 and U5 modifications.
    Iwakuma T; Cui Y; Chang LJ
    Virology; 1999 Aug; 261(1):120-32. PubMed ID: 10441560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased number of single-LTR HIV-1 DNA junctions correlates with HIV-1 antigen expression and CD4+ cell decline in vivo.
    Jurriaans S; de Ronde A; Dekker J; Cornelissen M; Goudsmit J
    J Med Virol; 1995 Jan; 45(1):91-8. PubMed ID: 7714497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.